A randomised, double-blind, placebo-controlled parallel group study to examine the safety, tolerability, and pharmacokinetics of repeat inhaled doses of GSK159797 in healthy subjects | NobleID
v1
A randomised, double-blind, placebo-controlled parallel group study to examine the safety, tolerability, and pharmacokinetics of repeat inhaled doses of GSK159797 in healthy subjects